0.3835
Schlusskurs vom Vortag:
$0.411
Offen:
$0.4199
24-Stunden-Volumen:
946.07K
Relative Volume:
0.12
Marktkapitalisierung:
$56.21M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-0.59
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
-1.67%
1M Leistung:
+24.27%
6M Leistung:
-60.18%
1J Leistung:
-77.70%
Biodesix Inc Stock (BDSX) Company Profile
Firmenname
Biodesix Inc
Sektor
Branche
Telefon
303-417-0500
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Vergleichen Sie BDSX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
0.3835 | 57.20M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
2024-09-16 | Eingeleitet | Scotiabank | Sector Outperform |
2024-07-26 | Eingeleitet | Craig Hallum | Buy |
2024-05-13 | Eingeleitet | TD Cowen | Buy |
2024-05-03 | Eingeleitet | Lake Street | Buy |
2021-11-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2020-11-23 | Eingeleitet | BTIG Research | Buy |
2020-11-23 | Eingeleitet | Canaccord Genuity | Buy |
2020-11-23 | Eingeleitet | Morgan Stanley | Overweight |
2020-11-23 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix (NASDAQ:BDSX) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Biodesix, Inc. Reports Strong Q2 2025 Growth - MSN
Biodesix at Canaccord Conference: Strategic Expansion in Diagnostics By Investing.com - Investing.com Canada
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Q2 2025 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. (NASDAQ:BDSX) Just Reported Earnings, And Analysts Cut Their Target Price - 富途牛牛
Earnings Release: Here's Why Analysts Cut Their Biodesix, Inc. (NASDAQ:BDSX) Price Target To US$1.80 - Yahoo Finance
Biodesix 2025 Q2 Earnings Revenue Grows 11.7% Amid Expanding Losses - AInvest
Biodesix reports strong Q2 revenue growth - BizWest
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates - MSN
Biodesix, Inc. shares fall 9.84% intraday despite Q2 revenue beating estimates. - AInvest
Transcript : Biodesix, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Biodesix Plunges 11.63% on Q2 Loss, Revenue Surprise - AInvest
Biodesix Reports Strong Q2 2025 Revenue Growth - TipRanks
Biodesix Maintains Hold Rating Amid Revenue Growth and Cash Flow Challenges - AInvest
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansion ... By GuruFocus - Investing.com Canada
Biodesix Inc (BDSX) Q2 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
Biodesix Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Biodesix Outpaces Expectations With Lung Test Growth And Upbeat Outlook - Finimize
Diagnostic firm Biodesix Q2 revenue beats estimates - MarketScreener
Biodesix earnings missed, revenue topped estimates By Investing.com - Investing.com South Africa
Biodesix earnings missed, revenue topped estimates - Investing.com
Biodesix Announces Second Quarter 2025 Results and Highlights - GlobeNewswire
Biodesix Soars 14.1% on Conference Presentation - AInvest
Biodesix Stock Soars 12.82% on Strong Q1 Earnings - AInvest
Biodesix shares rise 4.26% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView
Biodesix shares rise 1.30% premarket after announcing CEO and CFO to present at Canaccord Genuity 45th Annual Growth Conference. - AInvest
Biodesix's Strategic Momentum in Diagnostic Innovation and Market Expansion: A Compelling Buy in the High-Growth Diagnostics Sector - AInvest
Biodesix Leadership Team Set for Exclusive Fireside Chat at Major Growth Conference - Stock Titan
Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating - 富途牛牛
Why is Biodesix Inc. stock attracting strong analyst attentionMaximize portfolio value with timely trades - Jammu Links News
What institutional investors are buying Biodesix Inc. stockAchieve rapid portfolio appreciation today - Jammu Links News
What makes Biodesix Inc. stock price move sharplyFind market-beating stocks for your portfolio - Jammu Links News
Is Biodesix Inc. stock overvalued or undervaluedCapitalize on emerging market opportunities - Jammu Links News
Biodesix Inc. Stock Analysis and ForecastFree High-Return Strategy Alerts - Jammu Links News
Biodesix (BDSX) to Release Earnings on Thursday - MarketBeat
What catalysts could drive Biodesix Inc. stock higher in 2025Access high-quality stock research instantly - Jammu Links News
How many analysts rate Biodesix Inc. as a “Buy”Free Capital Allocation Plans - Jammu Links News
What are analysts’ price targets for Biodesix Inc. in the next 12 monthsOverwhelming profit margins - Jammu Links News
Is it the right time to buy Biodesix Inc. stockInvest smarter with expert trading signals - Jammu Links News
How strong is Biodesix Inc. company’s balance sheetFree Capital Allocation Plans - Jammu Links News
What analysts say about Biodesix Inc. stockDiscover high-growth stocks for your portfolio - Jammu Links News
How does Biodesix Inc. compare to its industry peersStay ahead with advanced stock screening tools - Jammu Links News
How does Biodesix Inc. generate profit in a changing economyStock Strategy Trend Scanner For Every Investor - jammulinksnews.com
What is Biodesix Inc. company’s growth strategyReal Time Tracker With High Returns - Jammu Links News
Biodesix Inc. Recovery Gathers Momentum on Chart SignalsNews Based Entry Opportunity Alerts Detected - metal.it
Finanzdaten der Biodesix Inc-Aktie (BDSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):